ShathaYounis MustafaFarhanMDAssistant Professor
Hematology • Detroit, MIHematologic Oncology
Stem cell transplant & cellular therapy
Dr. Farhan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2799 W Grand Blvd
Ste K13
Detroit, MI 48202Phone+1 313-916-5002- Is this information wrong?
Education & Training
Henry Ford HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011- Henry Ford HospitalResidency, Internal Medicine, 2005 - 2008
University of Jordan Faculty of MedicineClass of 2003
University of Texas M D Anderson Cancer CenterFellowship, Blood & Bone Marrow Transplant
Certifications & Licensure
MI State Medical License 2005 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib Start of enrollment: 2016 Mar 08
- Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant Start of enrollment: 2018 Mar 14
- Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant Start of enrollment: 2019 Jul 01
Publications & Presentations
PubMed
- 9 citationsAssociation between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal, Talha Badar, Sherif M Badawy, Karen Ballen, Amer Beitin...> ;Haematologica. 2023 Jul 1
- 1 citationsGraft-versus-host disease: teaching old drugs new tricks at less cost.Shatha Farhan, Shernan G Holtan> ;Frontiers in Immunology. 2023 Jan 1
- 9 citationsFludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetul Oran, Kwang Woo Ahn, Caitrin Fretham, Amer Beitinjaneh, Asad Bashey, Attaphol Pawarode, Baldeep Wirk, Bart L. Scott, Bipin N. Savani, Christopher Bredeson, Danie...> ;Transplantation and Cellular Therapy. 2021 Aug 14
- Join now to see all
Journal Articles
- Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Periphe...shatha farhan, Adv Hematology
Hospital Affiliations
Henry Ford HospitalDetroit, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
